Società | Nome | Borsa | Settore | Industria | Capitalizzazione di mercato | Rapporto Prezzo/Utile | Rapporto PEG | Ultimo prezzo di scambio | Variazione giornaliera (%) | Fair Value | Rialzo Fair Value | Etichetta Fair Value | Price Target (analisti) | Rialzo target analisti | Salute complessiva |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Apex Healthcare | Kuala Lumpur | Salute | Prodotti farmaceutici | 1,92 Mrd MYR | 21,5x | -0,28 | 2,67 MYR | -0,4% | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | 8,1% Rialzo | Fai l’upgrade a Pro+ | |
Duopharma Biotech | Kuala Lumpur | Salute | Prodotti farmaceutici | 1,34 Mrd MYR | 27,3x | -0,93 | 1,39 MYR | 0% | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | 4% Rialzo | Fai l’upgrade a Pro+ | |
Amway | Kuala Lumpur | Salute | Prodotti farmaceutici | 1,14 Mrd MYR | 8,4x | 0,12 | 6,94 MYR | 0,4% | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | -1,3% Ribasso | Fai l’upgrade a Pro+ | |
Kotra Industries | Kuala Lumpur | Salute | Prodotti farmaceutici | 648,13 Mln MYR | 14,2x | -0,45 | 4,37 MYR | 2,3% | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | -1,6% Ribasso | Fai l’upgrade a Pro+ | |
Pharmaniaga Bhd | Kuala Lumpur | Salute | Prodotti farmaceutici | 540,46 Mln MYR | -9,6x | -0,11 | 0,38 MYR | 0% | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | -9,3% Ribasso | Fai l’upgrade a Pro+ | |
YSP Southeast Asia | Kuala Lumpur | Salute | Prodotti farmaceutici | 347,52 Mln MYR | 11,1x | -0,49 | 2,45 MYR | 0,8% | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | ||
Rhone Ma | Kuala Lumpur | Salute | Prodotti farmaceutici | 153,75 Mln MYR | 12,4x | 3,81 | 0,69 MYR | 1,5% | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | 0,7% Rialzo | Fai l’upgrade a Pro+ | |
Bioalpha | Kuala Lumpur | Salute | Prodotti farmaceutici | 98,45 Mln MYR | -2,6x | -0,07 | 0,07 MYR | 7,7% | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ |